@article{BraunBockelmann2016, author = {Braun, Andreas and Bockelmann, Laura}, title = {An individual perspective on open innovation capabilities in the context of haute cuisine}, series = {International journal of innovation in management}, volume = {20}, journal = {International journal of innovation in management}, publisher = {World Scientific}, address = {Singapore}, issn = {1363-9196}, doi = {10.1142/S136391961650002X}, pages = {480 -- 499}, year = {2016}, abstract = {Previous research on open innovation (OI) has primarily focused on the organisational level of R\&D intensive industries. With this paper, we contribute to research on the individual level of analysis by analysing specific perspectives in the context of creative industries. Our study is based on 36 interviews with Haute cuisine chefs in France, Germany, Great Britain, Italy, Spain, Sweden, and Switzerland listed in the 2012 Michelin Guide. Building on the OI capability concept, our results demonstrate that chefs use absorptive and desorptive capacity (AC, DC) as means to generate and market culinary innovations, respectively. Moreover, we found that chefs almost exclusively rely on their own inventive and innovative capabilities in the early stages of the culinary innovation process. In subsequent phases, however, chefs increasingly integrate other sources such as employees, suppliers, and guests. Our study contributes to the literature in two ways. First, we research the individual level within the OI process, and second, we provide insight into OI practices in the creative industries.}, language = {en} } @article{UllrichVladovaMarquartetal.2022, author = {Ullrich, Andr{\´e} and Vladova, Gergana and Marquart, Danny and Braun, Andreas and Gronau, Norbert}, title = {An overwiew of benefits and risks in open innovation projects and the influence of intermediary participation, decision-making authority, experience, and position on their perception}, series = {International journal of innovation management : IJIM}, volume = {26}, journal = {International journal of innovation management : IJIM}, number = {02}, publisher = {World Scientific Publ.}, address = {Singapore}, issn = {1363-9196}, doi = {10.1142/S1363919622500128}, pages = {41}, year = {2022}, abstract = {This paper presents an exploratory study investigating the influence of the factors (1) intermediary participation, (2) decision-making authority, (3) position in the enterprise, and (4) experience in open innovation on the perception and assessment of the benefits and risks expected from participating in open innovation projects. For this purpose, an online survey was conducted in Germany, Austria and Switzerland. The result of this paper is an empirical evidence showing whether and how these factors affect the perception of potential benefits and risks expected within the context of open innovation project participation. Furthermore, the identified effects are discussed against the theory. Existing theory regarding the benefits and risks of open innovation is expanded by (1) finding that they are perceived mostly independently of the factors, (2) confirming the practical relevance of benefits and risks, and (3) enabling a finer distinction between their degrees of relevance according to respective contextual specifics.}, language = {en} } @article{BraunReger2009, author = {Braun, Andreas and Reger, Guido}, title = {Innovation, science and institutional change : a research handbook}, issn = {0033-6807}, doi = {10.1111/j.1467-9310.2008.00543_1.x}, year = {2009}, language = {en} } @article{RegerAdelhelmBraun2009, author = {Reger, Guido and Adelhelm, Silvia and Braun, Andreas}, title = {Lead User : von der Kundenorientierung zur Kundenintegration}, isbn = {978-3-428-13238-6}, year = {2009}, language = {de} } @article{AdelhelmBraunGronauetal.2014, author = {Adelhelm, Silvia and Braun, Andreas and Gronau, Norbert and L{\"u}rig, Detlef and M{\"u}ller, Elisabeth and Vladova, Gergana and Wagner, Dieter}, title = {Mit Open Innovation zum Erfolg}, series = {Handbuch prozessorientiertes Wissensmanagment}, journal = {Handbuch prozessorientiertes Wissensmanagment}, publisher = {GITO}, address = {Berlin}, isbn = {978-3-95545-026-7}, pages = {211 -- 226}, year = {2014}, language = {de} } @phdthesis{Braun2014, author = {Braun, Andreas}, title = {Open innovation - an analysis of the individual level}, address = {Potsdam}, pages = {219 S.}, year = {2014}, language = {en} } @book{AdelhelmBraunGronauetal.2010, author = {Adelhelm, Silvia and Braun, Andreas and Gronau, Norbert and M{\"u}ller, E. and Vladova, Gergana}, title = {Open Innovation : Methodologische Pr{\"a}zisierung und praktische Umsetzung im Projekt Open Innovation in Life Sciences}, isbn = {978-3-8396-0141-9}, year = {2010}, language = {de} } @book{AdelhelmBraunMuelleretal.2011, author = {Adelhelm, Silvia and Braun, Andreas and M{\"u}ller, Elisabeth and Vladova, Gergana}, title = {Philo : PharmaInnovationsLotse ; ihr Weg zum erfolgreichen Open Innovation Management}, publisher = {Universit{\"a}tsverlag Potsdam}, address = {Potsdam}, isbn = {978-3-86956-103-5}, url = {http://nbn-resolving.de/urn:nbn:de:kobv:517-opus-50895}, publisher = {Universit{\"a}t Potsdam}, pages = {161}, year = {2011}, abstract = {Vorliegender Leitfaden ist eines der Ergebnisse des Forschungsprojekts „Open Innovation in Life Sciences" (OIL), das von Mai 2008 bis April 2011 an der Universit{\"a}t Potsdam durchgef{\"u}hrt wurde. Er nimmt f{\"u}r sich in Anspruch, gerade Innovationsmanager in kleinen und mittleren Unternehmen (KMU) der Pharmaindustrie bei der Einf{\"u}hrung des Open Innovation Managements zu unterst{\"u}tzen. Zielsetzung des Forschungsprojekts war es, (1) die Chancen und Risiken von Open Innovation unter besonderer Ber{\"u}cksichtigung der Anforderungen von Pharma-KMU zu analysieren und (2) daraus abgeleitet ein Konzept zur Implementierung von Open Innovation bei Pharma-KMU zu entwickeln. Der Ausgangspunkt des Projektes war die Erkenntnis, dass die Life Sciences-Branche im Allgemeinen und die Pharmaindustrie im Besonderen durch eine steigende Komplexit{\"a}t der Innovationsprozesse und eine zunehmende Tendenz zu Kooperationen gekennzeichnet ist. Vor diesem Hintergrund er{\"o}ffnet gerade der Open Innovation-Ansatz f{\"u}r die Pharmabranche neue Gestaltungs- und damit Wachstumsm{\"o}glichkeiten. Open Innovation - definiert als die planvolle {\"O}ffnung der Innovationsprozesse und die strategische Einbindung des Unternehmensumfelds - wird dabei als zentraler Erfolgsfaktor f{\"u}r die Innovationsf{\"a}higkeit beschrieben.}, language = {de} }